• Ceapin-A7: A Strategic Probe for ER Stress Biology

  2026-09-01

  Ceapin-A7 gives translational researchers a focused way to interrogate ATF6α within the broader unfolded protein response. This article connects that pharmacology with emerging evidence on bone injury, apoptosis, inflammatory signaling, assay strategy, and decision-making beyond a typical product page.

• Aβ42 as a Translational Probe in Alzheimer’s Research

  2026-09-01

  A mechanistic and strategic guide to using Amyloid β-Peptide (1-42) as a controlled probe across microglial phagocytosis, neuronal toxicity, and ion-channel assays, with practical guidance for translational Alzheimer’s disease research.

• Mitoxantrone HCl: Beyond DNA Damage

  2026-08-31

  Mitoxantrone HCl is best known as a DNA topoisomerase II inhibitor, but emerging evidence positions mitoxantrone as a mechanistically broader research tool. By disrupting the estrogen receptor alpha DBD-LBD interface and promoting receptor degradation, it may help translational researchers study endocrine resistance alongside DNA damage, apoptosis, and tumor-cell vulnerability.

• Firefly Luciferase mRNA: Workflow and Applications

  2026-08-30

  Firefly Luciferase mRNA (ARCA, 5-moUTP) provides a sensitive, transient readout for delivery, translation, viability, and imaging experiments. This practical guide connects reporter assay design with nanoparticle formulation, handling, normalization, and troubleshooting for more reproducible results.

• Batimastat, BDNF, and the Next MMP Workflow

  2026-08-29

  Batimastat (BB-94) offers a practical way to interrogate how broad-spectrum MMP activity reshapes extracellular signaling, from tumor invasion and angiogenesis to proteolytic BDNF processing during neuromuscular junction development. This thought-leadership perspective connects a landmark BDNF study with translational assay design while distinguishing established evidence from testable hypotheses.

• Arctigenin Protects Against Doxorubicin Cardiotoxicity

  2026-08-29

  A Journal of Pharmaceutical Analysis study used a 960-compound natural-product screen to identify arctigenin as a candidate for reducing doxorubicin-induced cardiotoxicity. The work links protection of cardiac cells and mice to direct disruption of the KEAP1–NRF2 interaction, with associated reductions in oxidative stress, ferroptosis, and mitochondrial injury.

• TCEP Hydrochloride for Assay Design and Redox Control

  2026-08-28

  Tris(2-carboxyethyl) phosphine hydrochloride is more than a disulfide-reduction reagent: it is a controllable redox tool for protein preparation, analytical readouts, and assay development. This article connects its chemistry to capture-and-release lateral flow design while clearly separating established uses from emerging hypotheses.

• Rapamycin for mTOR and Uveal Melanoma Workflows

  2026-08-28

  Rapamycin (Sirolimus) provides a controllable mTOR perturbation for connecting autophagy, proliferation, and survival phenotypes in cancer, immunology, and mitochondrial disease assays. This workflow-focused guide shows how to deploy nanomolar treatment alongside STAT6/LINC01637 measurements without confusing pathway validation with proof of therapeutic efficacy.

• LY2228820: A Conformation-Aware Assay Guide

  2026-08-27

  LY2228820 is a selective p38 MAP kinase inhibitor for dissecting stress, inflammatory, and tumor-associated signaling. This guide connects target engagement to assay design, phosphatase biology, and interpretable cancer research readouts.

• Toremifene vs Tamoxifen in Advanced Breast Cancer

  2026-08-27

  This Cochrane review synthesizes randomized evidence comparing toremifene with tamoxifen for advanced breast cancer and finds no clear difference in tumor response, disease control, survival, or the evaluated adverse effects. Its main contribution is a structured head-to-head assessment that helps researchers distinguish evidence of comparable efficacy from evidence of true therapeutic equivalence.

• Dextromethorphan Hydrobromide: Neuroprotection Guide

  2026-08-26

  Dextromethorphan hydrobromide is a research-grade NMDA receptor antagonist used to examine glutamate excitotoxicity, ion-channel modulation, and neuroprotection. Product data report inhibition of NMDA-induced currents and voltage-operated inward currents, while the available evidence supports controlled laboratory interpretation rather than clinical efficacy claims.

• Cell Death in Liver Disease: Mechanisms and Clinical Impact

  2026-08-26

  Luedde, Kaplowitz, and Schwabe’s review reframes hepatocellular death as an active driver of inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma rather than merely a marker of liver injury. Its major practical contribution is to connect distinct death programs, damage-associated molecular patterns, biomarkers, and disease-stage-specific responses, while highlighting why therapeutic interpretation requires more than measuring ALT or AST.

• Hoechst 33258 for KRas/TNT Cell Assays

  2026-08-25

  Learn how Hoechst 33258 supports nuclear segmentation, live-cell tracking, and DNA-content measurements in tunneling nanotube and KRas heterogeneity studies. This workflow separates what the dye measures directly from the mechanical and oncogenic conclusions that require confocal imaging, optical tweezers, and genetic controls.

• 3-Bromopyruvate and Cetuximab in Resistant CRC

  2026-08-25

  The reference study shows that combining 3-bromopyruvate with cetuximab can suppress colorectal cancer cells that are intrinsically or adaptively resistant to cetuximab. Its central mechanistic insight is that FOXO3a reactivation connects AMPKα–Beclin1 signaling and PUMA induction with autophagy-dependent ferroptosis, apoptosis, and reduced tumor growth.

• CDC42 Polarity Controls Intestinal Stem Cell Fate

  2026-08-24

  Zhang et al. show that CDC42-dependent apical-basal polarity regulates the intestinal stem cell to transit-amplifying cell transition through a YAP/TAZ–Ereg–mTOR signaling cascade. The work separates this mechanism from canonical Wnt signaling and uses genetic and pharmacological interventions to connect epithelial organization with crypt proliferation.

451 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page